» Articles » PMID: 30546921

3D Biofabrication for Tubular Tissue Engineering

Overview
Journal Biodes Manuf
Date 2018 Dec 15
PMID 30546921
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

The therapeutic replacement of diseased tubular tissue is hindered by the availability and suitability of current donor, autologous and synthetically derived protheses. Artificially created, tissue engineered, constructs have the potential to alleviate these concerns with reduced autoimmune response, high anatomical accuracy, long-term patency and growth potential. The advent of 3D bioprinting technology has further supplemented the technological toolbox, opening up new biofabrication research opportunities and expanding the therapeutic potential of the field. In this review, we highlight the challenges facing those seeking to create artificial tubular tissue with its associated complex macro- and microscopic architecture. Current biofabrication approaches, including 3D printing techniques, are reviewed and future directions suggested.

Citing Articles

3D Porous Polycaprolactone with Chitosan-Graft-PCL Modified Surface for In Situ Tissue Engineering.

Pitts J, Hansch R, Roger Y, Hoffmann A, Menzel H Polymers (Basel). 2025; 17(3).

PMID: 39940585 PMC: 11820431. DOI: 10.3390/polym17030383.


Biofabrication and biomanufacturing in Ireland and the UK.

Murphy J, Lavelle M, Asciak L, Burdis R, Levis H, Ligorio C Biodes Manuf. 2024; 7(6):825-856.

PMID: 39650072 PMC: 11618173. DOI: 10.1007/s42242-024-00316-z.


Fabrication Method for Shape-Controlled 3D Tissue Using High-Porosity Porous Structure.

Ueno H, Yamamura S Bioengineering (Basel). 2024; 11(2).

PMID: 38391646 PMC: 10885993. DOI: 10.3390/bioengineering11020160.


Three-dimensional biofabrication of nanosecond laser micromachined nanofibre meshes for tissue engineered scaffolds.

McWilliam R, Chang W, Liu Z, Wang J, Han F, Black R Biomater Transl. 2024; 4(2):104-114.

PMID: 38283921 PMC: 10817787. DOI: 10.12336/biomatertransl.2023.02.005.


Polymeric reinforcements for cellularized collagen-based vascular wall models: influence of the scaffold architecture on the mechanical and biological properties.

Pien N, Di Francesco D, Copes F, Bartolf-Kopp M, Chausse V, Meeremans M Front Bioeng Biotechnol. 2023; 11:1285565.

PMID: 38053846 PMC: 10694796. DOI: 10.3389/fbioe.2023.1285565.


References
1.
Campbell G, Campbell J . Development of tissue engineered vascular grafts. Curr Pharm Biotechnol. 2007; 8(1):43-50. DOI: 10.2174/138920107779941426. View

2.
Itoh M, Nakayama K, Noguchi R, Kamohara K, Furukawa K, Uchihashi K . Scaffold-Free Tubular Tissues Created by a Bio-3D Printer Undergo Remodeling and Endothelialization when Implanted in Rat Aortae. PLoS One. 2015; 10(9):e0136681. PMC: 4556622. DOI: 10.1371/journal.pone.0136681. View

3.
Kang H, Lee S, Ko I, Kengla C, Yoo J, Atala A . A 3D bioprinting system to produce human-scale tissue constructs with structural integrity. Nat Biotechnol. 2016; 34(3):312-9. DOI: 10.1038/nbt.3413. View

4.
Shoichet M, Li R, White M, Winn S . Stability of hydrogels used in cell encapsulation: An in vitro comparison of alginate and agarose. Biotechnol Bioeng. 1996; 50(4):374-81. DOI: 10.1002/(SICI)1097-0290(19960520)50:4<374::AID-BIT4>3.0.CO;2-I. View

5.
Diniz I, Chen C, Xu X, Ansari S, Zadeh H, Marques M . Pluronic F-127 hydrogel as a promising scaffold for encapsulation of dental-derived mesenchymal stem cells. J Mater Sci Mater Med. 2015; 26(3):153. PMC: 4477746. DOI: 10.1007/s10856-015-5493-4. View